Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

NCT02201329 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndromes
Leukemia, Myelomonocytic, Chronic

Interventions

DRUG: Azacitidine
DRUG: Volasertib

Sponsor

Boehringer Ingelheim